Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

(

A-WISH

)

ITN Protocol #:

ITN030ST

Branded Name:

A-WISH

ClinicalTrials.Gov ID:

NCT00135694

Treatment Protocol #:

Immunosuppression withdrawal

Therapeutic Area:

Transplantation

Current Status:

Complete

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase II Trial to Assess the Safety of Immunosuppression Withdrawal in Liver Transplant Recipients

Clinical Operations Manager

ITN Biologist

NIAID Project Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Abraham Shaked, MD PhD abraham.shaked@uphs.upenn.edu

Work:

215-662-6723

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-353-4406

Protocol Chair

Kristina Harris, PhD

Work:

Protocol Chair

Allison Priore allison.girouard@nih.gov

Work:

240-627-3550

Protocol Chair

David Ikle, PhD David_Ikle@rhoworld.com

Work:

919-595-6378

Protocol Chair

Susan McCachren susan_mccachren@rhoworld.com

Work:

919-595-6391

Admin Links

Shortcuts

ITN Documents

Links